DexCom, Inc.
DXCM
Clasificación en acciones
#758
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Precio por acción
$85.72
Capitalización bursátil
$32.35B
Cambio (1 día)
-0.30%
Cambio (1 año)
25.27%
País
US
Comercio DexCom, Inc. (DXCM)
Categoría
Healthcare
Número de acciones en circulación de DexCom, Inc. (DXCM)
Número de acciones en circulación al June 2026: 383.70M
Según los últimos informes financieros y el precio de las acciones de DexCom, Inc., el número actual de acciones en circulación es 383.70M. Al final de December 2024, la empresa tenía 404.63M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de DexCom, Inc. (DXCM) desde 2000 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2026 (TTM) | 383.70M | -1.67% |
| 2025 | 390.20M | -3.57% |
| 2024 | 404.63M | 4.83% |
| 2023 | 386.00M | -0.87% |
| 2022 | 389.40M | 0.65% |
| 2021 | 386.90M | 2.46% |
| 2020 | 377.60M | 3.62% |
| 2019 | 364.40M | 3.29% |
| 2018 | 352.80M | 2.20% |
| 2017 | 345.20M | 3.23% |
| 2016 | 334.40M | 4.76% |
| 2015 | 319.20M | 6.12% |
| 2014 | 300.80M | 5.77% |
| 2013 | 284.40M | 3.49% |
| 2012 | 274.80M | 4.73% |
| 2011 | 262.40M | 15.29% |
| 2010 | 227.60M | 28.31% |
| 2009 | 177.39M | 50.40% |
| 2008 | 117.95M | 4.15% |
| 2007 | 113.25M | 3.95% |
| 2006 | 108.94M | 43.77% |
| 2005 | 75.78M | 728.71% |
| 2004 | 9.14M | 5.35% |
| 2003 | 8.68M | 6.05% |
| 2002 | 8.18M | 7.89% |
| 2001 | 7.59M | 9.81% |
| 2000 | 6.91M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| 1.74B | 354.27% |
US
|
|
| 1.28B | 234.14% |
IE
|
|
| 383.50M | -0.05% |
US
|
|
| 1.48B | 285.09% |
US
|
|
| - | - |
DE
|
